WallStreetZenWallStreetZen

NASDAQ: CURX
Curanex Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Curanex Pharmaceuticals earnings were -$4.2M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest CURX earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$3.1M, up 222.1% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CURX reported annual earnings of -$4.2M, with 1,068.8% growth.

CURX earnings history

Current Revenue
$0.0
Current Earnings
-$4.2M
Current Profit Margin
0%

CURX Return on Equity

Current Company
-64.5%
Current Industry
-31.4%
Current Market
28.9%
CURX's Return on Equity (-64.5%)... subscribe to Premium to read more.
High Return on Equity Performance

CURX Return on Assets

Current Company
-61.2%
Current Industry
-9.6%
CURX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CURX announces earnings.

CURX Return on Capital Employed

Current Company
-36.85%
Current Industry
-3.7%
CURX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CURX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CURX-$4.14M-$4.23MN/A-$0.17
BCDA-$7.72M-$8.23MN/A-$1.23
CYCN-$3.53M-$3.53MN/A-$1.11
CMMB-$8.93M-$9.00MN/A-$1.44
BLRX$628.00k-$1.18MN/A$0.00
View Top Biotech Stocks

Curanex Pharmaceuticals Earnings Reports & History FAQ

What were Curanex Pharmaceuticals's earnings last quarter?

Curanex Pharmaceuticals (NASDAQ: CURX) reported Q4 2025 earnings per share (EPS) of -$0.12, up 700% year over year. Total CURX earnings for the quarter were -$3.07 million. In the same quarter last year, Curanex Pharmaceuticals's earnings per share (EPS) was $0.02.

If you're new to stock investing, here's how to buy Curanex Pharmaceuticals stock.

Is Curanex Pharmaceuticals profitable or losing money?

As of the last Curanex Pharmaceuticals earnings report, Curanex Pharmaceuticals is currently losing money. Curanex Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$4.23 million, a 1,068.75% increase year over year.

What was CURX's earnings growth in the past year?

As of Curanex Pharmaceuticals's earnings date in Q2 2026, Curanex Pharmaceuticals's earnings has grown year over year. CURX earnings in the past year totalled -$4.23 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.